Stem cell governance in China: From bench to bedside?

New Genetics and Society

Volumn 28, Issue 3, 2009, Pages 267-282

  Chen, Haidan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

China; Governance; Stem cells; Translational research

Indexed keywords

BIOMEDICINE; BIOTECHNOLOGY; CASE REPORT; CHINA; CLINICAL TRIAL; HUMAN; MEDICAL RESEARCH; MULTICENTER STUDY; POLITICAL SYSTEM; PRIORITY JOURNAL; REVIEW; STEM CELL;

EID: 71949122122     PISSN: 14636778     EISSN: 14699915     Source Type: Journal    
DOI: 10.1080/14636770903151984     Document Type: Review

References (45)

1. Adams, J.U., 2008. Building the bridge from bench to bedside. Nature Reviews Drug Discovery, 7, 463-464.
2. Anon., 2008. What's in a name? Nature Reviews Drug Discovery, 5, 441.
3. Baker, M., 2008. Being patient. Nature, 45, 586-588.
4. Brown, N. and Kraft, A., 2006. Blood ties - banking the stem cell promise. Technology Analysis and Strategic Management, 3/4, 313-327.
5. Butler, D., 2008. Crossing the valley of death. Nature, 453, 840-842.
6. Deng, W., et al., 2004. Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Experimental Hematology, 32, 861-867.
7. Deng, W., et al., 2005. Engrafted bone marrow-derived flk-(1+) mesenchymal stem cells regenerate skin tissue. Tissue Engineering, 11, 110-119.
8. Economist. 2008. China's baby-milk scandal: formula for disaster. The Economist [online], 18 September. Available from: http://www.economist.com/ world/asia/displaystory.cfm?story-id=12262271 [Accessed 21 July 2009].
9. Einhorn, B., 2006. Blinding science: China's race to innovate. Business week [online], 31 March. Available from: http://www.businessweek.com/globalbiz/ content/mar2006/gb20060331-921612.htm [Accessed 14 August 2009].
10. Eriksson, L. and Webster, A., 2008. Standardising the unknown: practicable pluripotency as doable futures. Science as Culture, 17 (1), 57-69.
11. Fang, B., et al., 2003. Flt1+/CD31-/CD34- human fetal bone marrow cells are capable of multi-organ engraftment and multi-lineage differentiation in NOD/SCID mice. Journal of Hematotherapy and Stem Cell Research, 12 (6), 603-615.
12. FitzGerald, G.A., 2005. Anticipating change in drug development: the emerging era of translational medicine and therapeutics. Nature Reviews Drug Discovery, 4, 815-818.
13. Friedberg, E.C., 2008. An interview with Sydney Brenner. Nature Reviews Molecular Cell Biology, 9, 8-9.
14. Gottweis, H., 2009. Biopolitics in Asia. New Genetics and Society, 28, 201-204.
15. Gottweis, H., 2010. Biobanks - success or failure? Towards a comparative model. In: P. Dabrock, et al., eds. Trust in biobanking: dealing with ethical, legal and social issues in an emerging field of biotechnology. Series: Veröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim, Vol.33. Heidelberg: Springer (in press).
16. Guo, H., et al., 2003. Haemangioblastic characteristics of fetal bone marrow-derived Flk1+ CD31-CD34- Cells. Experimental Hematology, 31 (7), 650-658.
17. He, Y., 2006. ShenZhen's biotech ambition. China Entrepeneur (Chinese Journal), 9, 66-71.
18. Hö rig, H., Marincola, E., and Marincola, F.M., 2005. Obstacles and opportunities in translational research. Nature Medicine, 11, 705-708.
19. Hyun, I., et al., 2008. New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell, 3, 607-610.
20. ISSCR. 2008. Guidelines for the clinical translation of stem cells [online]. Available from: http://www.isscr.org/clinical-trans/index.cfm [Accessed 23 December 2008].
21. Jasanoff, S., 2004. The idiom of co-production. In: S. Jasanoff, ed. States of knowledge: the co-production of science and social order. London: Routledge, 1-12.
22. Jeffrey, S., 2009. First embryonic stem-cell-based therapy trial in spinal-cord injury gets FDA nod [online]. Available from: http://www.medscape. com/viewarticle/587411 [Accessed 12 February 2009].
23. Kraft, A., 2008. New light through an old window? What's new about "translation" in biomedical research? Paper presented at SATGS, the University of York, December.
24. Lau, D., et al., 2008. Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell, 3, 591-594.
25. Law, J., 1994. Organizing modernity. Oxford: Blackwell.
26. Lim, L., 2008. Stem-cell therapy in China draws foreign patients [online]. Available from: http://www.npr.org/templates/story/story.php?storyId= 88123868 [Accessed 8 February 2009].
27. Littman, B.H., et al., 2007. What's next in translational medicine? Clinical Science, 112, 217-227.
28. McCullough, M., 2008. Stem-cell tourism troubles experts [online]. Available from: http://www.evanoskyfoundation.org/Stem- cell%20tourism%20troubles%20experts.pdf [Accessed 8 February 2009].
29. Nelson, B., 2008. Stem cell researchers face down stem cell tourism. Nature Reports Stem Cells [online], 5 June. Available from: http://www.nature. com/stemcells/2008/0806/080605/full/stemcells.2008.89.html [Accessed 8 February 2009].
30. O'Connell, D. and Roblin, D., 2006. Translational research in the pharmaceutical industry: from bench to bedside. Drug Discovery Today, 11 (17/18), 833-838.
31. Pollack, A., 2009. F.D.A. approves a stem cell trial [online]. Available from: http://www.nytimes.com/2009/01/23/business/23stem.html?-r=1&hp [Accessed 12 February 2009].
32. PRC State Council, 2006. Medium- and long-term national plan for science and technology development 2006-2020. Available from: http://cordis.europa.eu/ erawatch/index.cfm?fuseaction=policy.document&uuid=C47F0281-C6D5-999E- D01CF3D4E651C63D [Accesed 21 July 2009].
33. Rose, N., 2008. Governance and biomedical research, Paper presented at BIONET Changsha Conference, March 2008.
34. Sabroe, I., et al., 2007. Identifying and hurdling obstacles to translational research. Nature Reviews Immunology, 7, 77-82.
35. Salter, B., Cooper, M., and Dickins, A., 2006. China and the global stem cell bioeconomy: an emerging political strategy? Regenerative Medicine, 1, 671-683.
36. Star, L. and Griesemer, J., 1989. Institutional ecology, "translations" and boundary objects: amateurs and professionals in Berkeley's Museum of Vertebrate Zoology, 1907-1939. Social Studies of Science, 19 (4), 387-420.
37. Tait, J. andWilliams, R., 1999. Policy approaches to research and development: foresight, framework and competitiveness. Science and Public Policy, 26 (2), 101-112.
38. Wahlberg, A. and Streitfellner, T., 2009. Tourisme de cellules souches, désespoir et pouvoir des nouvelles thérapies [Stem cell tourism, desperation and the governing of new therapies]. In: A. Leibing and V. Tournay, eds. Technologies de l'espoir. Les débats publics autour de l'innovation médicale (in press).
39. Wainwright, S., et al., 2006. From bench to bedside? Biomedical scientists' expectations of stem cell science as a future therapy for diabetes. Social Science & Medicine, 63 (8), 2052-2064.
40. Waldby, C. and Mitchell, R., 2006. Tissue economies: blood, organs and cell lines in late capitalism. Durham, NC: Duke University Press.
41. Walsh, F., 2009. Green light for US stem cell work [online]. Available from: http://news.bbc.co.uk/1/hi/health/7847450.stm [Accessed 12 February 2009].
42. Weissman, I., 2002. Stem cells - scientific, medical, and political issues. New England Journal of Medicine, 20 (346), 1576-1579.
43. Wilsdon, J. and Keeley, J., 2007. China: The next science superpower? The atlas of ideas: mapping the new geography of science. Demos Pamphlet. Atlas of Ideas Series. London: Demos. Available from: http://www.demos.co.uk/files/China- final.pdf [Accessed 21 July 2009].
44. Xinhua. 2008. China to upgrade Health Ministry to better monitor food and drug safety [online]. Available from: http://news.xinhuanet.com/english/2008- 03/11/content-7766320.htm [Accessed 12 February 2009].
45. Zhang,W., et al., 2004. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells and Development, 13, 263-271.